×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BEAT – heartbeam, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BEAT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/12
11:19 pm
beat
HeartBeam Inc (BEAT) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges with ... [Yahoo! Finance]
Low
Report
HeartBeam Inc (BEAT) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges with ... [Yahoo! Finance]
3/12
04:20 pm
beat
HeartBeam Reports Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
Medium
Report
HeartBeam Reports Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
3/12
04:01 pm
beat
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
Medium
Report
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
3/10
07:54 am
beat
HeartBeam enters strategic AI collaboration with Mount Sinai [Seeking Alpha]
High
Report
HeartBeam enters strategic AI collaboration with Mount Sinai [Seeking Alpha]
3/10
07:28 am
beat
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home [Yahoo! Finance]
High
Report
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home [Yahoo! Finance]
3/10
07:00 am
beat
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
High
Report
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
3/9
07:16 am
beat
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch [Yahoo! Finance]
Medium
Report
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch [Yahoo! Finance]
3/9
07:00 am
beat
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch
Medium
Report
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/12
04:03 pm
beat
Form 10-K HeartBeam, Inc. For: Dec 31
Medium
Report
Form 10-K HeartBeam, Inc. For: Dec 31
12/22
05:44 pm
beat
Form 4 HeartBeam, Inc. For: Dec 17 Filed by: STROME MARK E
Medium
Report
Form 4 HeartBeam, Inc. For: Dec 17 Filed by: STROME MARK E
12/19
05:10 pm
beat
Form 4 HeartBeam, Inc. For: Dec 17 Filed by: de Urioste George
Low
Report
Form 4 HeartBeam, Inc. For: Dec 17 Filed by: de Urioste George
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
Form DEFA14A BIOTELEMETRY, INC.
10.2%
11/6 BioTelemetry Inc (NASDAQ: BEAT) had its "buy" rating re-affirmed by analysts at Lake Street Capital. They now have a $80.00 price target on the stock, down previously from $90.00. 8.8%
3/19 BioTelemetry Inc (NASDAQ: BEAT) had its price target lowered by analysts at Benchmark Co. from $82.00 to $55.00. They now have a "buy" rating on the stock. 6.9%
4/22 BioTelemetry Inc (NASDAQ: BEAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $47.00 price target on the stock. 6.3%
1/6 Form 4 BIOTELEMETRY, INC. For: Dec 31 Filed by: Ferola Peter 5.4%
4/27 BioTelemetry, Inc. to Move to Virtual-only Annual Stockholder Meeting for 2020 5.0%
7/30 Q2/2019 6/30/2019 EPS 0.530 ZacksConsensus 0.450 ActVsEst 0.080 - Beat 4.9%
11/4 BioTelemetry Q3 Earnings Preview [Seeking Alpha] 4.4%
4/8 Form 4 BIOTELEMETRY, INC. For: Apr 06 Filed by: Stoica Andrei G 3.6%
10/11 BioTelemetry Inc (NASDAQ: BEAT) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%
11/6 BioTelemetry Inc (NASDAQ: BEAT) had its "buy" rating re-affirmed by analysts at Lake Street Capital. They now have a $80.00 price target on the stock, down previously from $90.00. 8.8%
3/19 BioTelemetry Inc (NASDAQ: BEAT) had its price target lowered by analysts at Benchmark Co. from $82.00 to $55.00. They now have a "buy" rating on the stock. 6.9%
4/22 BioTelemetry Inc (NASDAQ: BEAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $47.00 price target on the stock. 6.3%
1/6 Form 4 BIOTELEMETRY, INC. For: Dec 31 Filed by: Ferola Peter 5.4%
4/27 BioTelemetry, Inc. to Move to Virtual-only Annual Stockholder Meeting for 2020 5.0%
7/30 Q2/2019 6/30/2019 EPS 0.530 ZacksConsensus 0.450 ActVsEst 0.080 - Beat 4.9%
11/4 BioTelemetry Q3 Earnings Preview [Seeking Alpha] 4.4%
4/8 Form 4 BIOTELEMETRY, INC. For: Apr 06 Filed by: Stoica Andrei G 3.6%
10/11 BioTelemetry Inc (NASDAQ: BEAT) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%
TOP News Decliners
2/26
Q4/2019 12/31/2019 EPS 0.480 ZacksConsensus 0.480 ActVsEst 0.000 - In-Line
-6.2%
11/9 BioTelemetry Inc (NASDAQ: BEAT) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
8/1 BioTelemetry Inc (NASDAQ: BEAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $53.00 price target on the stock. -5.5%
7/30 BioTelemetry Inc (BEAT) Q2 2019 Earnings Call Transcript [The Motley Fool] -5.4%
2/28 Form 10-K BIOTELEMETRY, INC. For: Dec 31 -5.1%
2/20 Form 4 BIOTELEMETRY, INC. For: Feb 18 Filed by: Capper Joseph H -4.5%
6/26 BioTelemetry Inc (NASDAQ: BEAT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -4.1%
8/14 BioTelemetry: A Strong Buy At 52-Week Lows As A Key Part Of Apple's Heart Study Innovation [Seeking Alpha] -3.8%
4/27 BioTelemetry Inc (NASDAQ: BEAT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.1%
5/21 Form 4/A BIOTELEMETRY, INC. For: May 03 Filed by: GORMAN KIRK E -3.0%
11/9 BioTelemetry Inc (NASDAQ: BEAT) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
8/1 BioTelemetry Inc (NASDAQ: BEAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $53.00 price target on the stock. -5.5%
7/30 BioTelemetry Inc (BEAT) Q2 2019 Earnings Call Transcript [The Motley Fool] -5.4%
2/28 Form 10-K BIOTELEMETRY, INC. For: Dec 31 -5.1%
2/20 Form 4 BIOTELEMETRY, INC. For: Feb 18 Filed by: Capper Joseph H -4.5%
6/26 BioTelemetry Inc (NASDAQ: BEAT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -4.1%
8/14 BioTelemetry: A Strong Buy At 52-Week Lows As A Key Part Of Apple's Heart Study Innovation [Seeking Alpha] -3.8%
4/27 BioTelemetry Inc (NASDAQ: BEAT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.1%
5/21 Form 4/A BIOTELEMETRY, INC. For: May 03 Filed by: GORMAN KIRK E -3.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: